M Bruno

Summary

Affiliation: Lofarma S.p.A
Country: Italy

Publications

  1. ncbi LAIS - Posological schedules
    M Bruno
    Medical Department, Lofarma S.p.A, Milan, Italy
    Int J Immunopathol Pharmacol 18:33-4. 2005
  2. ncbi Specific immunotherapy [correction of immunotheraphy] of allergic diseases: a three years perspective observational study
    A Arena
    ASL 5, Messina, Italy
    Int J Immunopathol Pharmacol 16:277-82. 2003
  3. ncbi Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites
    G Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy
    Allergy 61:849-54. 2006

Collaborators

Detail Information

Publications3

  1. ncbi LAIS - Posological schedules
    M Bruno
    Medical Department, Lofarma S.p.A, Milan, Italy
    Int J Immunopathol Pharmacol 18:33-4. 2005
  2. ncbi Specific immunotherapy [correction of immunotheraphy] of allergic diseases: a three years perspective observational study
    A Arena
    ASL 5, Messina, Italy
    Int J Immunopathol Pharmacol 16:277-82. 2003
    ....
  3. ncbi Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites
    G Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy
    Allergy 61:849-54. 2006
    ..The need for extra visits was significantly lower in the active group (25%vs 43%). CONCLUSIONS: Sublingual immunotherapy was clinically effective and safe in mite-induced mild disease...